Intelligent Investing News
Intelligent Investing News
|
AMAG PHARMACEUTICALS INC. Financials
|
|
|
What Investors Think About AMAG Pharmaceuticals
|
|
|
AMAG PHARMACEUTICALS INC. Files SEC form 10-Q, Quarterly Report
|
|
|
AMAG Pharmaceuticals, Inc. to Present at Canaccord Genuity 30th Annual Global Growth Conference
|
[Business Wire] - LEXINGTON, Mass.----AMAG Pharmaceuticals, Inc. today announced that management will present an overview of the company at the Canaccord Genuity 30th Annual Global Growth Conference on August 10, 2010 at 9:00 a.m.
|
|
AMAG Misses Consensus, Narrows Loss
|
|
|
Red Ink Rules Out Leap For Quantum
|
|
|
[video] Thursday Earnings Losers: QTM, SRDX, CTV, AMAG, ARRS
|
|
|
Biotech Stocks: AMAG, Covance slide; Genzyme gains on M&A talk
|
[at MarketWatch] - AMAG Pharmaceuticals Inc. shares fell in afternoon trading Thursday, the day after the company issued an earnings report that fell shy of Wall Street expectations.
|
|
Biotech Stocks: AMAG, Covance slide on earnings reports
|
|
|
AMAG slides on earnings report, downgrade
|
|
|
AMAG Pharma downgraded by Robert W. Baird
|
|
|
AMAG Pharmaceuticals, Inc. Q2 2010 Earnings Call Transcript
|
|
|
AMAG Pharmaceuticals, Inc. Earnings Call scheduled for 4:30 pm ET today
|
|
|
AMAG Pharmaceuticals Announces Financial Results for the Second Quarter and Six Months Ended June 30, 2010
|
[Business Wire] - LEXINGTON, Mass.----AMAG Pharmaceuticals, Inc. , a biopharmaceutical company focused on the development and commercialization of a therapeutic iron compound to treat iron deficiency anemia and novel imaging agents to aid in the diagnosis of cancer and cardiovascular disease, today reported unaudited consolidated financial results for the second quarter and six months ended June 30, 2010.
|
|
AMAG PHARMACEUTICALS INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and
|
|
|
Q2 2010 AMAG Pharmaceuticals, Inc. Earnings Release - After Market Close
|
|
|
AMAG Pharmaceuticals, Inc. to Host Conference Call to Discuss Financial Results for the Second Quarter on July 28, 2010 at 4:30 p.m. ET
|
[Business Wire] - LEXINGTON, Mass.----AMAG Pharmaceuticals, Inc. today announced it will report unaudited consolidated financial results for the quarter ended June 30, 2010 after the U.S. financial markets close on July 28, 2010.
|
|
IDEXX Laboratories (IDXX) A Strong Buy For Senior Analyst With Kaufman Bros.; 9% Organic Revenue Growth For Last Quarter Shows Companys Maturity
|
|
|
AMAG Pharmaceuticals and Takeda Announce Acceptance of Submission of Feraheme® Marketing Authorization Application to the European Medicines Agency
|
[Business Wire] - LEXINGTON, Mass. & OSAKA, Japan----AMAG Pharmaceuticals, Inc. and Takeda Pharmaceutical Company Limited today provided a regulatory and clinical update for Feraheme® Injection for intravenous use.
|
|
The 10 Most Heavily Shorted U.S. Stocks
|
|
Intelligent Investing News
Intelligent Investing News
